Transcripts

Quest Diagnostics (DGX) earnings call transcripts

Earnings call transcripts for Quest Diagnostics, with a summary, the guidance given, and what analysts pressed on.

  • Q3 2026 earnings call

    Management framed the quarter as broad-based, productivity-supported growth, while emphasizing PAMA uncertainty and strong underlying demand across customer channels.

    Oct 22, 2026Confident0.72
  • Q2 2026 earnings call

    Management portrayed demand as broad and durable, with strong utilization offsetting ACA uncertainty, launch costs, fuel inflation and Corewell ramp dilution.

    Jul 23, 2026Confident0.78
  • Q4 2025 earnings call

    Management framed 2026 as sustained organic growth, with healthcare partnerships, consumer diagnostics and productivity offsetting investment and weather pressures.

    Feb 10, 2026Confident0.72